Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

Share Price is delayed by 15 minutes
Get Live Data
657.20    -5.80 (-0.87%)
Bid:
658.00
Ask:
658.20
Spread: 0.20 (0.03%)
Market Cap: £52.31b
NWG Live PriceLast checked at - London Stock Exchange

Intraday Natwest Share Chart

Director/PDMR Shareholding

10 Nov 2022 15:53

RNS Number : 0384G
NatWest Group plc
10 November 2022
 

10 November 2022

 

NatWest Group plc

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY (PDMRs) in accordance with Article 19 of the Market Abuse Regulation

 

1. NatWest Group plc (the Company) announces that ordinary shares of £1.0769* each in the Company (Shares) (ISIN:GB00BM8PJY71) were delivered to PDMRs on 7 November 2022, under the NatWest Group 2014 Employee Share Plan (the Plan), as set out below. 

 

The Shares delivered represent payment of a fixed share allowance (FSA) for the three month period ending 31 December 2022 and have been calculated using a Share price of £2.3316.

 

The number of Shares delivered, the number of Shares withheld to meet associated tax liabilities and the number of Shares retained by each PDMR is as follows:-

 

Name of PDMR

Position of PDMR

No. of Shares delivered

No. of Shares withheld to satisfy associated tax liability

 

No. of Shares retained

 

Robert Begbie

 

 

CEO, NatWest Markets

16,084

7,732

8,352

 

Peter Flavel

 

 

CEO, Wealth Businesses

26,806

12,618

14,188

 

Bruce Fletcher

 

Chief Risk Officer, NatWest Group

 

35,920

16,908

19,012

 

David Lindberg

 

 

CEO, Retail Banking

34,848

16,404

18,444

 

Scott Marcar

 

Chief Information Officer

 

57,633

27,129

30,504

 

 

Andrew McLaughlin

 

 

CEO, Commercial & Institutional for the non-ring-fenced bank

 

2,145

1,010

1,135

 

Katie Murray

 

Chief Financial Officer

 

82,026

38,611

43,4151

 

Alison Rose

 

 

Chief Executive Officer

 

120,304

56,628

63,6761

 

 

John-Paul Thwaite

 

CEO, Commercial & Institutional for the ring-fenced bank

 

33,508

15,773

17,735

 

Jen Tippin

 

Chief People & Transformation Officer

 

44,230

20,820

23,410

1. The shares will be released in instalments over a five year period.

* Note: the nominal value of ordinary shares without rounding is £1.076923076923077 per share

 

The market price used to determine the number of Shares withheld to meet associated tax liabilities was £2.3812. Shares retained after payment of associated tax liabilities will be held on behalf of PDMRs in the Computershare Share Plan Account and will be released in instalments over a three year period, unless otherwise indicated above.

 

2. The Company also announces that it has been notified of the PDMR set out below selling Shares on the date and at the price indicated:

 

Name of PDMR

Position of PDMR

No. of Shares sold

Price of Shares sold

 

Date Shares sold

 

Alison Rose

 

Chief Executive Officer

 

 

250,000

 

£2.3910

 

10 November 2022

 

 

3. The Company also announces that on 7 November 2022, a conditional Buy-out award (Award) was granted under the Plan to the PDMR set out below in order to replace awards forfeited by the individual on leaving their previous employer.

 

Name of PDMR

Position of PDMR

Award price

No. of Shares granted

Scott Marcar

Chief Information Officer

£2.61692

581,681

 

2. The Award price has been calculated using a 5 day average Share price taken immediately prior to the PDMR joining the Company.

 

 

 

The above transactions took place on the London Stock Exchange (XLON).

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

 

For further information contact:-

 

NatWest Group Investor RelationsAlexander Holcroft

Head of Investor Relations+44(0)20 7672 1758

 

NatWest Group Media Relations 

+44(0)131 523 4205

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFFISEESEIF
Date   Source Headline
27th Dec 20235:18 pmRNSTransaction in Own Shares
22nd Dec 20231:27 pmRNSTransaction in Own Shares
21st Dec 20235:23 pmRNSTransaction in Own Shares
20th Dec 20235:35 pmRNSTransaction in Own Shares
19th Dec 20235:33 pmRNSTransaction in Own Shares
19th Dec 20233:00 pmRNSDirector/PDMR Shareholding
18th Dec 20235:31 pmRNSTransaction in Own Shares
15th Dec 20235:25 pmRNSTransaction in Own Shares
15th Dec 20239:00 amRNSKey findings from Phase 2 of Travers Smith review
13th Dec 20235:32 pmRNSTransaction in Own Shares
12th Dec 20235:29 pmRNSTransaction in Own Shares
11th Dec 20239:38 amRNSHolding(s) in Company
8th Dec 20239:46 amRNSPublication of a Prospectus
7th Dec 20235:18 pmRNSTransaction in Own Shares
6th Dec 20235:30 pmRNSTransaction in Own Shares
5th Dec 20235:07 pmRNSTransaction in Own Shares
4th Dec 20235:12 pmRNSTransaction in Own Shares
1st Dec 20235:41 pmRNSTransaction in Own Shares
1st Dec 20239:52 amRNSTotal Voting Rights
29th Nov 20235:57 pmRNSTransaction in Own Shares
28th Nov 20235:31 pmRNSTransaction in Own Shares
27th Nov 20235:35 pmRNSTransaction in Own Shares
24th Nov 20235:34 pmRNSTransaction in Own Shares
23rd Nov 20235:27 pmRNSTransaction in Own Shares
23rd Nov 20233:39 pmRNSDividend Declaration
22nd Nov 20235:39 pmRNSTransaction in Own Shares
22nd Nov 20238:30 amRNSJPMorgan UK Leaders Conference
21st Nov 20235:54 pmRNSTransaction in Own Shares
21st Nov 20232:00 pmRNSDirector/PDMR Shareholding
20th Nov 20235:09 pmRNSTransaction in Own Shares
16th Nov 20235:33 pmRNSTransaction in Own Shares
14th Nov 20235:36 pmRNSTransaction in Own Shares
13th Nov 20235:04 pmRNSTransaction in Own Shares
13th Nov 20237:00 amRNSQ3 2023 Pillar 3
10th Nov 20235:06 pmRNSTransaction in Own Shares
10th Nov 20239:30 amRNSSection 430 (2B) Companies Act 2006 Statement
9th Nov 20235:05 pmRNSTransaction in Own Shares
9th Nov 20232:00 pmRNSDirector/PDMR Shareholding
8th Nov 20235:14 pmRNSTransaction in Own Shares
6th Nov 20235:17 pmRNSTransaction in Own Shares
3rd Nov 20236:02 pmRNSTransaction in Own Shares
2nd Nov 20235:13 pmRNSTransaction in Own Shares
1st Nov 20235:38 pmRNSTransaction in Own Shares
31st Oct 20236:07 pmRNSTransaction in Own Shares
31st Oct 20235:51 pmRNSTotal Voting Rights
31st Oct 20233:00 pmRNSDirector/PDMR Shareholding
30th Oct 20235:56 pmRNSTransaction in Own Shares
27th Oct 20235:26 pmRNSTransaction in Own Shares
27th Oct 20234:59 pmRNSPublication of Supplementary Prospectus
27th Oct 20237:00 amRNSNWG plc Q3 2023 Interim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.